Do you want to read an article? Please log in or register.
Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis
Lung Cancer
RECOMMENDED
Related content
RECOMMENDED
Tuberculosis
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Glob Health.
Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R
doi: 10.1016/S2214-109X(20)30227-8.
RECOMMENDED
Lung Cancer
Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Lebrett MB, Balata H, Evison M, Colligan D, Duerden R, Elton P, Greaves M, Howells J, Irion K, Karunaratne D, Lyons J, Mellor S, Myerscough A, Newton T, Sharman A, Smith E, Taylor B, Taylor S, Walsham A, Whittaker J, Barber PV, Tonge J, Robbins HA, Booton R, Crosbie PAJ
doi: 10.1136/thoraxjnl-2020-214626.
COMMENTED
Lung Cancer
Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study
Thorax.
Barclay ME, Lyratzopoulos G, Walter FM, Jefferies S, Peake MD, Rintoul RC
doi: 10.1136/thoraxjnl-2018-212456.
RECOMMENDED
Lung Cancer
Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Fisher A, Kim S, Farhat D, Belzer K, Milczuk M, French C, Mamdani H, Sukari A, Baciewicz F, Schwartz AG, Wozniak A, Nagasaka M
doi: 10.1016/j.cllc.2021.04.004
RECOMMENDED
Lung Cancer
Real-world guideline-based treatment of lung cancer improves short- and long-term outcomes and resection rate: A population-based study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer.
Helminen O, Valo J, Andersen H, Lautamäki A, Vuohelainen V, Sihvo E
doi: 10.1016/j.lungcan.2019.12.002.
RECOMMENDED
Lung Cancer
Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer.
Elbanna M, Shiue K, Edwards D, Cerra-Franco A, Agrawal N, Hinton J, Mereniuk T, Huang C, Ryan JL, Smith J, Aaron VD, Burney H, Zang Y, Holmes J, Langer M, Zellars R, Lautenschlaeger T
doi: 10.1016/j.cllc.2020.05.024.
RECOMMENDED
Lung Cancer
Local ablative treatment for synchronous single organ oligometastatic lung cancer - A propensity score analysis of 180 patients
Lung Cancer.
Frost N, Tessmer A, Schmittel A, van Laak V, Raspe M, Ruwwe-Glösenkamp C, Brunn M, Senger C, Böhmer D, Ochsenreither S, Temmesfeld-Wollbrück B, Furth C, Schmidt B, Neudecker J, Rückert JC, Suttorp N, Witzenrath M, Grohé C
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer.
Oh MS, Guzner A, Wainwright DA, Mohindra NA, Chae YK, Behdad A, Villaflor VM
doi: 10.1016/j.cllc.2020.07.016.
COPD
SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts
Respir Res.
Beckmeyer-Borowko A, Imboden M, Rezwan FI, Wielscher M, Amaral AFS, Jeong A, Schaffner E, Auvinen J, Sebert S, Karhunen V, Bettschart R, Turk A, Pons M, Stolz D, Kronenberg F, Arathimos R, Sharp GC, Relton C, Henderson AJ, Jarvelin MR, Jarvis D, Holloway JW, Probst-Hensch NM
doi: 10.1186/s12931-018-0850-8.